Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Wilton

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
European Journal of Endocrinology|July 13, 2016
Treatment with high doses of pegvisomant in 56 patients with acromegaly: experience from ACROSTUDYAart Jan van der Lely, Peter Jönsson, Patrick Wilton, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2010
Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database)Vera Popovic, Anders F Mattsson, Rolf C Gaillard, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|May 11, 2012
GH deficiency during the transition period: clinical characteristics before and after GH replacement therapy in two different subgroups of patientsHugo L Fideleff, Björn Jonsson, Maria Koltowska-Häggström, et al.
Hormone Research|January 18, 2007
Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short statureMichael B Ranke, Anders Lindberg, David A Price, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database)Michael B Ranke, Anders Lindberg, Christopher T Cowell, et al.
European Journal of Endocrinology|August 21, 2008
GH replacement in hypopituitarism improves lipid profile and quality of life independently of changes in obesity variablesPascale Abrams, Hugo Boquete, Hugo Fideleff, et al.
European Journal of Endocrinology|December 6, 2012
Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysisRoger Abs, Anders F Mattsson, Maria Thunander, et al.
European Journal of Endocrinology|June 24, 2006
Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysisRoger Abs, Ulla Feldt-Rasmussen, Anders F Mattsson, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|January 4, 2003
A growth prediction model for short children born small for gestational ageMichael B Ranke, Wayne S Cutfield, Anders Lindberg, et al.
Acta Paediatrica (Oslo, Norway : 1992)|September 20, 2006
Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database)Feyza Darendeliler, Georgios Karagiannis, Patrick Wilton, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
European Journal of Endocrinology|July 13, 2016
Treatment with high doses of pegvisomant in 56 patients with acromegaly: experience from ACROSTUDYAart Jan van der Lely, Peter Jönsson, Patrick Wilton, et al.
The Journal of Clinical Endocrinology and Metabolism|July 9, 2010
Serum insulin-like growth factor I (IGF-I), IGF-binding proteins 2 and 3, and the risk for development of malignancies in adults with growth hormone (GH) deficiency treated with GH: data from KIMS (Pfizer International Metabolic Database)Vera Popovic, Anders F Mattsson, Rolf C Gaillard, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|May 11, 2012
GH deficiency during the transition period: clinical characteristics before and after GH replacement therapy in two different subgroups of patientsHugo L Fideleff, Björn Jonsson, Maria Koltowska-Häggström, et al.
Hormone Research|January 18, 2007
Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short statureMichael B Ranke, Anders Lindberg, David A Price, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database)Michael B Ranke, Anders Lindberg, Christopher T Cowell, et al.
European Journal of Endocrinology|August 21, 2008
GH replacement in hypopituitarism improves lipid profile and quality of life independently of changes in obesity variablesPascale Abrams, Hugo Boquete, Hugo Fideleff, et al.
European Journal of Endocrinology|December 6, 2012
Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysisRoger Abs, Anders F Mattsson, Maria Thunander, et al.
European Journal of Endocrinology|June 24, 2006
Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysisRoger Abs, Ulla Feldt-Rasmussen, Anders F Mattsson, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|January 4, 2003
A growth prediction model for short children born small for gestational ageMichael B Ranke, Wayne S Cutfield, Anders Lindberg, et al.
Acta Paediatrica (Oslo, Norway : 1992)|September 20, 2006
Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database)Feyza Darendeliler, Georgios Karagiannis, Patrick Wilton, et al.
Pageof 3